ERS Online course

View all ERS courses

Virtual school on lung transplantation - Advanced level

Organisers : G. Verleden, G. Massard, F. Meloni
Faculty : A. Olland, A. M. Holm, A. Neyrinck, D. Van Raemdonck, M. Perch.

The virtual school on lung transplantation will provide state-of-the-art knowledge on a wide array of issues regarding lung transplantation. It will include innovative and interactive sessions such as pro/con debates or the study of cases from participants. Through its basic and advanced-level programmes, the virtual school is aimed at catering to the educational needs of participants with a basic and advanced understanding of the subject. Each programme will last half a day and it will be delivered online.

This webpage is dedicated to the advanced level edition. You may register for both the basic and advanced level programmes. For further information on the basic level programme, please visit:

Throughout the advanced programme, learners will gain an insight into chronic lung allograft dysfunction (CLAD), definition, phenotypes, and pathogenesis. Similarly, participants will learn about lymphoproliferative disease, other malignancies, non heart-beating donors, and ex-vivo donor lung perfusion.

This course has been accredited with 4 CME credits by the European Accreditation Council for Continuing Medical Education (EACCME). The number of credits that you will receive corresponds to your attendance during the live online course only.

Course format

  • Lectures
  • case discussion
  • interactive workshops

Target audience

  • Transplant physicians
  • Surgeons
  • Nurses
  • Physiotherapists


  • CLAD definition, ClAD phenotypes, definition and pathogenesis
  • Lung transplantation in post-ARDS
  • Lymphoproliferative disease and other malignancies
  • Donation after circulatory death
  • Ex-vivo donor lung perfusion

Learning outcomes

Following this course, participants will have an advanced level knowledge on lung transplantation issues such as CLAD, lymphoproliferative disease and other malignancies, donation after circulatory death and ex-vivo donor lung perfusion .